Similar Adherence Rates Favor Different Virologic Outcomes for Patients Treated with Nonnucleoside Analogues or Protease Inhibitors

This publication has 18 references indexed in Scilit:

• A Proof‐of‐Concept Study of Short‐Cycle Intermittent Antiretroviral Therapy with a Once‐Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV Infection
  The Journal of Infectious Diseases, 2004
• Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine- or Efavirenz-Based Antiretroviral Therapy
  Clinical Infectious Diseases, 2004
• Measuring Adherence to Antiretroviral Therapy in a Diverse Population Using a Visual Analogue Scale
  HIV Research & Clinical Practice, 2004
• Adherence, Quality of Life, and General Satisfaction with Co-formulated Zidovudine, Lamivudine, and Abacavir on Antiretroviral-Experienced Patients
  HIV Research & Clinical Practice, 2004
• High levels of adherence do not prevent accumulation of HIV drug resistance mutations
  AIDS, 2003
• Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens
  AIDS, 2003
• Simpler Regimens May Enhance Adherence to Antiretrovirals in HIV-Infected Patients
  HIV Research & Clinical Practice, 2002
• Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
• Measuring Adherence to Antiretroviral Medications in Clinical Trials
  HIV Research & Clinical Practice, 2000
• Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
  AIDS Care, 2000